BioCryst Pharmaceuticals, Inc.BioCryst Pharmaceuticals, Inc.BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪983.34 M‬USD
−1.18USD
‪−226.54 M‬USD
‪331.41 M‬USD
‪198.56 M‬
Beta (1Y)
0.84

About BioCryst Pharmaceuticals, Inc.

CEO
Jon P. Stonehouse
Headquarters
Durham
Employees (FY)
536
Founded
1986
ISIN
US09058V1035
FIGI
BBG000BLYWX6
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BCRX is 4.77 USD — it has decreased by 6.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioCryst Pharmaceuticals, Inc. stocks are traded under the ticker BCRX.
BioCryst Pharmaceuticals, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BioCryst Pharmaceuticals, Inc. has a max estimate of 30.00 USD and a min estimate of 6.00 USD.
BCRX earnings for the last quarter are −0.19 USD whereas the estimation was −0.25 USD which accounts for 22.45% surprise. Estimated earnings for the next quarter are −0.25 USD. See more details about BioCryst Pharmaceuticals, Inc. earnings.
BioCryst Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪86.74 M‬ USD despite the estimated figure of ‪86.06 M‬ USD. In the next quarter revenue is expected to reach ‪89.97 M‬ USD.
Yes, you can track BioCryst Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BCRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioCryst Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BCRX reached its all-time high on Mar 9, 2000 with the price of 37.25 USD, and its all-time low was 0.60 USD and was reached on Jun 26, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 536.00 employees. See our rating of the largest employees — is BioCryst Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioCryst Pharmaceuticals, Inc. EBITDA is ‪−102.05 M‬ USD, and current EBITDA margin is −30.79%. See more stats in BioCryst Pharmaceuticals, Inc. financial statements.